Metformin and aspirin: some "new" cancer treatments? Prevention and anti-tumoral activity

被引：1
作者：
Arrondeau, J. [1 ]
Bost, F. [2 ]
机构：
[1] Hop Cochin, Serv Oncol Med, F-75005 Paris, France
[2] Univ Nice Sophia Antipolis, INSERM, U1065, Equipe 7, F-06204 Nice 03, France
来源：
ONCOLOGIE | 2013年 / 15卷 / 09期
关键词：
Cancer; Metformin; Aspirin; AMPK/mTOR; Cyclooxygenase; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ACTIVATED PROTEIN-KINASE; LOW-DOSE ASPIRIN; LONG-TERM USE; COLORECTAL-CANCER; RANDOMIZED-TRIAL; BREAST-CANCER; PROSTATE-CANCER; IN-VIVO; RISK;
D O I：
10.1007/s10269-013-2319-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recently, old drugs such as the anti-diabetic agent metformin and aspirin have been found to display anti-tumoral properties. Indeed, there are more and more evidence showing that these drugs affect cancer cell proliferation and decrease tumor growth in various animal models. In this review, we summarize fundamental, pre-clinical, and clinical studies which describe metformin and aspirin action in cancer.
引用
收藏
页码：480 / 489
页数：10
相关论文
共 80 条
[1]   Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo [J].
Algire, C. ;
Amrein, L. ;
Bazile, M. ;
David, S. ;
Zakikhani, M. ;
Pollak, M. .
ONCOGENE, 2011, 30 (10) :1174-1182
[2]   Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase [J].
Algire, Carolyn ;
Amrein, Lilian ;
Zakikhani, Mahvash ;
Panasci, Lawrence ;
Pollak, Michael .
ENDOCRINE-RELATED CANCER, 2010, 17 (02) :351-360
[3]   Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials [J].
Algra, Annemijn M. ;
Rothwell, Peter M. .
LANCET ONCOLOGY, 2012, 13 (05) :518-527
[4]   Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice [J].
Anisimov, VN ;
Berstein, LM ;
Egormin, PA ;
Piskunova, TS ;
Popovich, IG ;
Zabezhinski, MA ;
Kovalenko, IG ;
Poroshina, TE ;
Semenchenko, AV ;
Provinciali, M ;
Re, F ;
Franceschi, C .
EXPERIMENTAL GERONTOLOGY, 2005, 40 (8-9) :685-693
[5]  
[Anonymous], ANN ONCOL
[6]  
[Anonymous], 1997, IARC HDB CANC PREV, V1
[7]   Metformin, an Antidiabetic Agent, Suppresses the Production of Tumor Necrosis Factor and Tissue Factor by Inhibiting Early Growth Response Factor-1 Expression in Human Monocytes in Vitro [J].
Arai, Masatoku ;
Uchiba, Mitsuhiro ;
Komura, Hidefumi ;
Mizuochi, Yuichiro ;
Harada, Naoaki ;
Okajima, Kenji .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (01) :206-213
[8]   Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: A systematic review [J].
Asano, TK ;
McLeod, RS .
DISEASES OF THE COLON & RECTUM, 2004, 47 (05) :665-673
[9]   Metformin and the Incidence of Prostate Cancer in Patients with Type 2 Diabetes [J].
Azoulay, Laurent ;
Dell'Aniello, Sophie ;
Gagnon, Bruno ;
Pollak, Michael ;
Suissa, Samy .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (02) :337-344
[10]   A randomized trial of aspirin to prevent colorectal adenomas [J].
Baron, JA ;
Cole, BF ;
Sandler, RS ;
Haile, RW ;
Ahnen, D ;
Bresalier, R ;
McKeown-Eyssen, G ;
Summers, RW ;
Rothstein, R ;
Burke, CA ;
Snover, DC ;
Church, TR ;
Allen, JI ;
Beach, M ;
Beck, GJ ;
Bond, JH ;
Byers, T ;
Greenberg, ER ;
Mandel, JS ;
Marcon, N ;
Mott, LA ;
Pearson, L ;
Saibil, F ;
van Stolk, RU .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10) :891-899
12345678